맞춤형 의료용 나노재료 : 세계 시장

Highlights:

The global market for nanomaterials in personalized medicine is expected to increase from $346.7 billion in 2023 to $592.0 billion by the end of 2028, with a compound annual growth rate (CAGR) of 11.3% during the forecast period of 2023-2028.

Proteins market for nanomaterials in personalized medicine is expected to increase from $112.8 billion in 2023 to $203.2 billion by the end of 2028, with a CAGR of 12.5% during the forecast period of 2023-2028.

Monoclonal antibodies market for nanomaterials in personalized medicine is expected to increase from $78.0 billion in 2023 to $136.4 billion by the end of 2028, with a CAGR of 11.8% during the forecast period of 2023-2028.

Report Scope:

The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.

The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.

Report Includes:

• 27 data tables and 50 additional tables
• An overview of the global market for nanomaterials in personalized medicine
• Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
• Discussions of the current and future market potential, and quantification of the market by product type and region
• Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
• Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
• Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
• Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
• Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
• Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
• Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma

Table of Contents

Chapter 1 Introduction

• Overview of Nanotheranostics
• Polymeric Nanomaterials
• Magnetic Nanomaterials
• Silica-Based Nanomaterials
• Carbon Nanomaterials
• Composite Nanomaterials
• Biologic Nanomaterials: Antibody, Proteins and DNA
• Carbon Nanotubes
• Other Nanomaterials
• Multifunctional Nanomaterials
• Drug Delivery
• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in this Update?
• Methodology
• Information Sources
• Geographic Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Market Insights

Chapter 3 Market Overview

• Market Overview
• Theranostics and Personalized Medicines Overview
• Nanoparticles
• Passive Targeting
• Active Targeting
• Nanotechnology Overview
• Size Definition
• Shape
• Surface Area
• Nanotheranostic Drug Delivery
• In Vivo Drug-Release Studies
• Drug Efficacy
• Future Perspectives

Chapter 4 Nanodevices and Nanomaterials in Diagnostics

• Overview
• Molecular Recognition in Diagnosis
• Nanopatterned Devices
• Particles
• Carbon Nanotubes
• Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
• Cancer Photothermal Therapy
• Carbon Nanotubes for Other Therapeutic Applications
• Fullerene C60
• C60 Toxicity
• Uptake and Biodistribution
• Antioxidant Properties
• Endohedrals
• Magnetic Resonance Imaging
• Radionuclides
• Photodynamic Therapy
• DNA Photocleavage
• Cancer
• Enzymes, Viruses, and Bacteria Inhibition
• Drug and Gene Delivery
• Magnetic Nanoparticles
• Hyperthermia
• Magnetic Separation
• Imaging and Delivery
• Brain Tumor Delivery
• Prostate Cancer
• Bladder Tumors
• Quantum Dots
• Aptamer-Conjugated Nanoparticles
• Nanoparticle-Based Bio-Bar Codes
• Multiplex Dendrimers
• Surface Enhanced Raman Spectroscopy
• Diagnostic and Medical Device Industry
• Multifunctional Nanoparticles
• Polymeric Nanoparticles in Cancer Therapy
• Polymeric-Based Imaging Probes for Cancer Imaging
• Quantum Dots in Cancer Imaging and Therapy
• Quantum Dots in Photodynamic Therapy and Imaging
• Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
• Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
• Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
• Gold Nanoparticles for Photothermal Therapy
• Gold Nanoshells
• Gold Nanorods
• Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
• Conclusion and Future Trends

Chapter 5 Treatments Based on Nanomaterial for Infections Associated with Medical Devices

• Infections Associated with Medical Devices and Their Treatments
• Catheter-Associated Infections
• Soft-Tissue-Implant-Associated Infections
• Biofilm Formation
• Common Methods for Preventing and Treating Medical Device-Associated Infections
• Nanomaterials in Medical Applications
• Nanomaterials in Personalized Medicine
• Antimicrobial Nanomaterials
• Silver Nanoparticles
• Zinc Oxide
• Iron and Iron-Oxide Nanoparticles
• Titanium Oxide
• Carbon Nanotubes and Fullerenes
• Chitosan
• Cytotoxicity Consideration

Chapter 6 Biomedical Nanoparticle Products

• Introduction
• Contract Manufacturing Organizations
• Information Technology
• Nanoparticle Drug Delivery Systems and Products
• Nanoparticle Drug Delivery Systems
• Company Pipelines for Nanoparticle Drug Delivery

Chapter 7 Therapeutic and Diagnostic Companion Kits

• Introduction

Chapter 8 Market Dynamics

• Market Drivers
• Rising Prevalence of Chronic Diseases Globally
• Rising Cancer Cases Globally
• Cancer Mortality
• Increasing Number of Diabetes Cases Worldwide
• Rising Worldwide Cases of Hypercholesterolemia
• Other major drivers in the personalized medicine market are:
• Market Restraints
• Challenges with Personalized Medicine
• Market Opportunities
• Nanodrug Delivery for the Treatment of Neurological Disorders
• Increasing Government Investment in Healthcare Sectors
• Rising Healthcare Costs
• Consumer Expectations

Chapter 9 Regulatory Landscape

• Overview
• Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
• Regulatory Issues in Nanotechnology
• Nanomedicines in the Pharmaceutical Market
• Market Access and Pharmacoeconomics

Chapter 10 Impact of COVID-19 on the Market

• Overview
• Structure of COVID-19 and Penetration
• COVID-19 Crisis
• Impact of COVID-19 on Nanomaterials in Personalized Medicine
• Novel Coronavirus Relying on Various Approaches
• Challenges in Vaccine Disruptions
• Components and Methods in the Design of a Vaccine
• Antigens
• Adjuvants
• Nanoparticles/Nanocarriers
• Devices
• Next-Generation Vaccines Enabled Through Advances in Nanotechnology
• Conclusions Regarding Use of Nanotechnology to Combat COVID-19
• COVID-19 Measures

Chapter 11 Market Breakdown by Product Type

• Market Overview
• Proteins
• Monoclonal Antibodies (mAbs)
• Monoclonal Antibody Therapy
• Mechanism
• Nanocrystals
• Nanocrystals Fabrication
• Liposomes
• Liposome Classification and Preparation
• Sonication
• Extrusion
• Freeze-Thawed Liposomes
• Solvent Dispersion Method
• Detergent-Removal Method
• Stealth Liposome
• Antibody-Liposome Conjugate
• Liposome Application in Medicine and Pharmacology
• Liposomes in Parasite Diseases and Infections
• Liposomes in Anticancer Therapies
• In Vitro Optical Imaging
• Gold Nanocarrier
• Hyperthermia
• Contrast Enhancers
• Radiotherapy
• Quantum Dots as Nanocarriers
• Photophysical Properties, Drug-Delivery and Drug-Release Sensing
• Visualizing Intracellular Uptake In Vitro
• Nanocarrier Biodistribution In Vivo
• Short Interfering RNA and DNA delivery

Chapter 12 Market Breakdown by Region

• Overview
• North America
• U.S. Market Size and Forecast
• Canada Market Size and Forecast
• Europe
• Germany Market Size and Forecast
• U.K. Market Size and Forecast
• France Market Size and Forecast
• Italy Market Size and Forecast
• Spain Market Size and Forecast
• Rest of European Market Size and Forecast
• Asia-Pacific
• China Market Size and Forecast
• Japan Market Size and Forecast
• India Market Size and Forecast
• South Korea Market Size and Forecast
• Rest of Asia-Pacific Market Size and Forecast
• Rest of the World
• South America Market Size and Forecast
• Middle East and Africa Market Size and Forecast

Chapter 13 ESG Development

• Introduction to ESG
• Environmental
• Social
• Government
• The Sustainability of Major Companies in the Industry
• Pharma End User Sustainability in the Industry
• Case Study
• Concluding Remarks from BCC

Chapter 14 Emerging Technologies

• Overview
• Current Market Trends
• Emerging Technologies
• Biomarkers
• Deep Phenotyping Technologies
• Digital Precision Medicine
• Genetics
• Health Information Technology

Chapter 15 Patents and Pipeline Analysis

• Overview
• Patent Analysis
• Pipeline Analysis

Chapter 16 M&A Outlook

• M&A Analysis
• Major Strategic Alliances

Chapter 17 Competitive Landscape

• Overview
• Distribution of Nanobiotechnology and Nanomedicine Companies
• Company Share Analysis

Chapter 18 Company Profiles

• BRISTOL-MYERS SQUIBB
• CAMURUS AB
• CYTIMMUNE SCIENCES
• EISAI
• GILEAD SCIENCES INC.
• IPSEN PHARMA

Chapter 19 Appendix: Acronyms